Exploring the Financial Burden Associated with the Management of Dystrophic Epidermolysis Bullosa (DEB): A Systematic Literature Review (SLR) with Database Review of Future Disease-Modifying Therapies (DMTs)

ALLO-ASC-SHEET - Anterogen

PTR-01 - BridgeBio

prademagene zamikeracel (EB-101) - Abeona Therap

Vyjuvek (beremagene geperpavec) - Krystal Biotech

FCX-007 - Precigen, Paragon Biosci

Bodke A1; Crossley O2; Knott C3; Samuels E4; Tang M3

Mar 8, 2024